Averaging down is often a very bad thing to do. Given that post-split, they have increased the number of outstanding shares by more then 20 times, from 13 million to 293 million or something like that means that there should be considerable downward pressure on the stock price. Yes, 200 million are restricted, but that means that 70 to 93 million are unrestricted, and that's 5 - 7 the total number of total shares post split (if only considering the unrestricted shares). It's possible that the S-11 will include offering more shares, so that too could be a problem. So, word to the wise is to take losses, and maybe get back in prior to the second quarter report, when news of revenue might boost the stock. I don't think that the first quarter report will tell us anything about the revenue, but it should show more expenses with the medical office building acquisition. If it doesn't show those expenses, then run, as this stock would really be stinky.
News 
Market Data 
Discover 
